Insights

Recent Acquisitions Bioscript Group's recent acquisitions of Enzyme Communications and Meridian HealthComms showcase their commitment to expanding services, presenting potential sales opportunities for partnerships or new client engagements.

Executive Leadership The appointment of Dr. Gabrielle Silver as CEO indicates Bioscript Group's strategic focus on enhancing scientific communication services, offering sales teams an opportunity to align solutions with the new leadership's vision.

Industry Competitive Positioning Within the competitive landscape of pharmaceutical communication, Bioscript Group's diverse range of services and expertise differentiates them, presenting a unique sales proposition for tailored solutions to potential clients.

Financial Stability With a revenue range of $10M - 50M, Bioscript Group's financial health positions them as a stable partner for long-term collaborations, offering sales professionals a foundation for pitching sustained value and reliability.

Tech Stack Integration Bioscript Group's utilization of advanced technologies like Xero, Cloudflare, and HubSpot highlights a commitment to innovation, presenting sales opportunities to offer tech-integrated solutions to streamline client services.

Similar companies to Bioscript Group

Bioscript Group Tech Stack

Bioscript Group uses 8 technology products and services including Xero, Cloudflare, HubSpot, and more. Explore Bioscript Group's tech stack below.

Xero
Accounting
Cloudflare
Content Management System
HubSpot
Marketing Automation
Yoast SEO
Search Engines
Cloudflare Bot Management
Security
Skype
Unified Communications
Adobe Fonts
Web Fonts
Nginx
Web Servers

Media & News

Bioscript Group's Email Address Formats

Bioscript Group uses at least 1 format(s):

Bioscript Group Email Formats	Example	Percentage
First.Last@bioscriptgroup.com	John.Doe@bioscriptgroup.com	97%
Last.First@bioscriptgroup.com	Doe.John@bioscriptgroup.com	1%
First.MiddleLast@bioscriptgroup.com	John.MichaelDoe@bioscriptgroup.com	1%
First.Middle@bioscriptgroup.com	John.Michael@bioscriptgroup.com	1%

Frequently Asked Questions

Where is Bioscript Group's headquarters located?

Bioscript Group's main headquarters is located at Larkwood Way Greenway House Macclesfield, England SK10 2XR GB. The company has employees across 5 continents, including EuropeNorth AmericaAsia.

What is Bioscript Group's official website and social media links?

Bioscript Group's official website is bioscriptgroup.com and has social profiles on LinkedIn.

How much revenue does Bioscript Group generate?

As of March 2025, Bioscript Group's annual revenue reached $15M.

What is Bioscript Group's NAICS code?

Bioscript Group's NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Bioscript Group have currently?

As of March 2025, Bioscript Group has approximately 144 employees across 5 continents, including EuropeNorth AmericaAsia. Key team members include Chief Information Officer: M. C.Chief Financial Officer: J. M.Director Of Finance: K. B. A.. Explore Bioscript Group's employee directory with LeadIQ.

What industry does Bioscript Group belong to?

Bioscript Group operates in the Pharmaceutical Manufacturing industry.

What technology does Bioscript Group use?

Bioscript Group's tech stack includes XeroCloudflareHubSpotYoast SEOCloudflare Bot ManagementSkypeAdobe FontsNginx.

What is Bioscript Group's email format?

Bioscript Group's email format typically follows the pattern of . Find more Bioscript Group email formats with LeadIQ.

When was Bioscript Group founded?

Bioscript Group was founded in 2005.

Bioscript Group

Pharmaceutical ManufacturingEngland, United Kingdom51-200 Employees

Established in 2005, Bioscript Group is formed from multiple, specialist businesses to support our global pharmaceutical clients; we draw on their multidisciplinary expertise to help navigate critical decisions at key points in the product lifecycle. 

Our scientific and strategic expertise help our clients make better decisions. We provide medical communication services, market access consulting and regulatory writing support with deep domain expertise to effectively navigate complex disease areas.